BioMarin Pharmaceutical (BMRN)

38.64 +0.13  +0.34%  May 25, 11:00PM Go Pro
You must be signed in to use watchlists.
Sign In or Register
Watch this stock

BioMarin Pharmaceutical R&D Expense: 73.83M

Get Interactive Chart for


of


Select a metric
 
Date range: to
<Embed Chart> Pro Save as Image Pro Data Export
Copy the code below and paste
into the embed destination.
  Done
Attention OK

BMRN R&D Expense Rankings

Overall 8th percentile 1613 of 1764
Sector 7th percentile 380 of 413 in Healthcare
Industry 5th percentile 142 of 150 in Biotechnology

BMRN R&D Expense Range, Past 5 Years

Minimum 17.24M Sep 2007
Maximum 73.83M Mar 2012
Average 35.22M

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

You may also be interested in these BMRN related companies

Display in Live Stream: Done
Options

BMRN News

@Fibline what do you think of $BMRN ?
about a day ago by 1nvestor
B/O watch over 39 $BMRN http://chart.ly/8kvd7jp
about 2 days ago by 1nvestor
Low Beta - High RS long candidates: $GNC $ALXN $FDO $BMRN $TSS $MO $HSY
about 3 days ago by hertcapital
HIGH $PUT VOLU $BMRN 7351% $EXAS 3722% $ARBA 2010% $NDAQ 941% $CFN 689% $CPB 641% $TSCO 543% $FTNT 536% $ORLY 488% $BLK 464%
about 6 days ago by livevol_pro
HIGH $PUT VOLU $BMRN 7351% $EXAS 3722% $ARBA 1997% $NDAQ 623% $FTNT 533% $TSCO 526% $CSC 422% $CFN 369% $AEO 287% $ORLY 277%
about 7 days ago by livevol_pro
$BMRN where are we going?
about 11 days ago by iLinx
Five Stocks Hit 52-Week Highs $RDWR $CHDN $LL $BMRN $MTH http://stks.co/3rG6 My story via @TheStreet
about 11 days ago by azendrian
$BMRN Insider Sale: $1.5M of stock sold by Bienaime Jean Jacques between May 11, 2012 - May 14, 2012 http://stks.co/3qP6
about 12 days ago by MarketBrief
$BMRN Insider Sale: $1.6M of stock sold by Davis George Eric on May 11, 2012 http://stks.co/3qOj
about 12 days ago by MarketBrief
Select long idea for today. $AKRX $BMRN $CYBX $CERN $OGE $OKE $SAM $SLXP $TRV
about 13 days ago by hertcapital
Select TR1 long ideas for tomorrow. $EQIX $RYL $PPG $ARBA $EBAY $AVB $BGS $SAM $BMRN
about 14 days ago by hertcapital
Listen to $BMRN inc. at deutsche bank ag health care conference - live at 08:00 AM, ondemand after - http://stks.co/3jp6
about 19 days ago by earningscast
$BMRN Insider Sale: $1.1M of stock sold by Bienaime Jean Jacques between May 1, 2012 - May 2, 2012 http://stks.co/3elV
about 24 days ago by MarketBrief
Wider Loss at BioMarin
Apr 30, 7:44AM
Listen to $BMRN Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3XW8
about 31 days ago by earningscast
$BMRN http://stks.co/3Njb $BMRN, Buy at trendline &amp; 200 day ma support. Robust pipeline
about 40 days ago by Catalystrader
$BMRN http://stks.co/3IgM Weekly triangle break down. Worth watch for new setup after new up correction http://stks.co/3IgN
about 47 days ago by xpertstocktrader
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DE1
about 54 days ago by MarketBrief
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C5Q
about 55 days ago by MarketBrief
$BMRN filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3Amr
about 56 days ago by MarketBrief
BioMarin Raised to Neutral
Mar 14, 10:30AM

Recent Quotes

Symbol Price Chg Chg % Market Cap
BMRN 38.64 +0.13 +0.34% 4.468B
BMJ 0.93 +0.00 +0.00%
BMI 36.69 -0.25 -0.68% 550.35M
BMC 43.69 +0.72 +1.68% 7.175B
BMA 13.46 -0.33 -2.39% 785.12M
BLX 19.14 -0.08 -0.42% 540.90M
BLV 93.83 +0.41 +0.44%
BLTI 2.42 +0.06 +2.54% 74.27M
BLT 13.53 -0.11 -0.81% 662.16M
BLRX 2.51 -0.03 -1.18% 31.02M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close